Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.9B | 10.1B | 9.8B | 10.0B |
| Cost of revenue | 3.6B | 7.8B | 7.6B | 7.7B |
| Gross profit | 1.3B | 2.3B | 2.3B | 2.3B |
| Operating expense | ||||
| Research & development | 149M | 971M | 1.0B | 1.1B |
| Selling general and admin | 713M | 945M | 945M | 989M |
| Other operating expenses | — | — | — | — |
| Operating income | 422M | 337M | 291M | 217M |
| Non operating interest income | ||||
| Income | 19M | 24M | 28M | 27M |
| Expense | 80M | 126M | 110M | 110M |
| Other income expense | — | — | — | — |
| Pretax income | 342M | 742M | 677M | 450M |
| Tax provision | 136M | 302M | 180M | 137M |
| Net income | 71M | 441M | 497M | 313M |
| Basic EPS | 0.0 | — | 0.2 | 0.2 |
| Diluted EPS | 0.0 | — | 0.2 | 0.2 |
| Basic average shares | 2B | — | 2B | 2.0B |
| Diluted average shares | 2B | — | 2B | 2.0B |
| EBITDA | 658M | 1.5B | 1.4B | 1.1B |
| Net income from continuing op. | 207M | 441M | 497M | 313M |
| Minority interests | -3M | -11M | -11M | -8M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |